STAT Virtual Event: The State of Biosimilars: What to Watch

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Read the rest…